Keywords: intercell, ixiaro, je, vacc, s-p, temodal, iv

Intercell's Ixiaro JE vacc and S-P's Temodal IV recommended for EU approval

Article | 22 December 2008

Print This

Germany's Intercell AG says that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMEA) has reached ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in